Sorafenib With Interferon Alfa-2b As First-Line Treatment of Advanced Renal Carcinoma: A Phase II Study of the Southwest Oncology Group
Ryan, C. W., Goldman, B. H., Lara, P. N., Mack, P. C., Beer, T. M., Tangen, C. M., Lemmon, D., Pan, C.-X., Drabkin, H. A., Crawford, E. D.Volume:
25
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2007.11.1047
Date:
August, 2007
File:
PDF, 121 KB
english, 2007